Lynx Global Digital Finance Corporation
Lynx Global Digital Finance Corporation (CNONF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cnonf · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Healthcare Information Services · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Lynx Global Digital Finance CorporationYou CNONF | $0M | N/A | — | -$0.04 |
 Astellas Pharma Inc. ALPMF | $25.9B | 15.65x | -48.4% | $163.79 |
 bioMérieux S.A. BMXXY | $9.9B | 33.13x | +9.3% | $0.32 |
 Coloplast A/S CLPBY | $13.4B | 35.71x | +17.8% | $1.52 |
 Wellbeing Digital Sciences Inc. KONEF | $0M | N/A | — | -$0.21 |
 Orion Oyj ORINY | $22.9B | 36.71x | +21.2% | $0.85 |
Industry Average 4 peers with valid PE | — | 30.30x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Lynx Global Digital Finance Corporation (CNONF) measures how much investors pay for each dollar of the company's trailing earnings. CNONF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.04.
Frequently asked questions
CNONF pe ratio · 6 questionsCNONF's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.00 and TTM EPS of -$0.04. Data sourced from Financial Modeling Prep via CNONF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lynx Global Digital Finance Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10